Clinical Trial Update: Fluoxetine on Motor Rehabilitation After Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fluoxetine for motor rehabilitation after ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Ischemic Stroke, Motor Impairment | Phase 2 | Status: COMPLETED